Physician
Hematology
Dr. Leonard R. Farber, MD
|
|
Give Review
Leonard Farber works in the field of Hematology. He graduated from State University of New York Downstate Medical Center College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Leonard Farber is also a published doctor. He has 16 paper published. The most recent paper is: Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with Malignant melanoma.
- High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.
- Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell Cancer.
- Second Neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
- The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal Cancer.
- Mediastinal irradiation in combined modality therapy for Hodgkin's disease.
- Gallium scans in patients with Mediastinal Hodgkin's disease treated with chemotherapy.
- A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
- The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
- Second solid Malignancies after combined modality therapy for Hodgkin's disease.
- Pseudohyperparathyroidism in head and neck Tumors.
- Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
- Second solid Tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
- Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast Cancer is feasible in the community setting.
- Stage I and II subdiaphragmatic Hodgkin's disease.
Schools
Suny Downstate Medical Center
Boston City Hospital
Yale
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Connecticare HMO
- Connecticare POS
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Freedom Plan
- Oxford Liberty
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Boston University Medical Center -
State University of New York Downstate Medical Center College of Medicine
Drug Facts
| NPI NUMBER | 1003846502 | |
| NPPES Provider LastName | FARBER | |
| NPPES Provider FirstName | LEONARD | |
| NPPES Provider ZIPCode | 06520 | |
| NPPES Provider State | CT | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 123.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 10.57 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003846502 |
| Last Name Of The Provider | FARBER |
| First Name Of The Provider | LEONARD |
| View All |
Similar Doctors
|
|
Dr. Andrea L. Silber, MD |
|
|
Dr. Samuel Bobrow, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold Tara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas M. Duffy, OD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John C. Rhee, MD |